Recombinant Cynomolgus PSGL-1 Protein

Recombinant Biotinylated Human OX40/TNFRSF4/CD134 Protein (Primary Amine Labeling),hFc Tag性能參數(shù)分子別名（Synonyms）OX40Lreceptor;CD134;TNFRSF4;Ly-70表達區(qū)間及表達系統(tǒng)（Source）BiotinylatedHumanOX40/TNFRSF4/CD134Protein(PrimaryAmineLabeling)isexpressedfromHEK293withhFctagattheC-Terminus.ItcontainsLeu29-Ala216.[Accession|P43489]分子量大?。∕olecularWeight）TheproteinhasapredictedMWof46.8kDa.Duetoglycosylation,theproteinmigratesto72-75kDabasedonSDS-PAGEresult.（Endotoxin）Lessthan1EUperμgbytheLALmethod.純度（Purity）>95%asdeterminedbySDS-PAGE制劑（Formulation）Suppliedas0.22μmfilteredsolutioninPBS(pH7.4).儲存條件Theproductshouldbestoredat-85~-65℃for1yearfromdateofreceipt.Recommendtoaliquottheproteinintosmallerquantitieswhenfirstusedandavoidrepeatedfreeze-thawcycles.通過泛素-蛋白體途徑(UPP)中的酶與底物蛋白共價連接，并在26S蛋白體降解ATP依賴的細胞蛋白中發(fā)揮主要作用。Recombinant Cynomolgus PSGL-1 Protein,His Tag

SARS-CoV-2,whichcausestheglobalpandemiccoronavirusdisease2019(Covid-19),belongstoafamilyofvirusesknownascoronaviruses.TheSARS-CoV-2Sproteinisaglycoproteinthatmediatesmembranefusionandviralentry.TheRBDofSARS-CoV-2bindsametallopeptidase,angiotensin-convertingenzyme2(ACE-2).SeveralemergingSARS-CoV-2genomeshavebeenidentifiedincludingtheOmicron,orB.1.1.529,variant.FirstidentifiedinNovember2021inSouthAfrica,theOmicronvariantquicklybecamethepredominantSARS-CoV-2variantandisconsideredavariantofconcern(VOC).TheOmicronvariantcontains15mutationsinRBDdomainthatpotentiallyaffectviralfitnessandtransmissibility.ThemajorityofthemutationsareinvolvedinACE-2bindingandOmicronbindsACE-2withgreateraffinity,potentiallyexplainingitsincreasedtransmissibility.Severalofthesemutationsarealsoidentifiedinfacilitatingimmuneescapeandreducingneutralizationactivitytoseveralmonoclonalantibodies.Recombinant Human GHR/Growth Hormone R (His Tag)CX3CL1受到促炎性刺激的上調(diào)，包括巨噬細胞，樹突狀細胞，內(nèi)皮細胞，神經(jīng)元，平滑肌，上皮細胞的細胞類型。

PE-labeled Human HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Tetramer Protein,His-Avi Tag性能參數(shù)表達區(qū)間及表達系統(tǒng)（Source）PE-labeledHumanHLA-A*02:01&B2M&P53R175H(HMTEVVRHC)TetramerProteinisexpressedfromHEK293withHistagandAvitagattheC-Terminus.PE-labeledHumanHLA-A*02:01&B2M&P53R175H(HMTEVVRHC)TetramerisassembledbybiotinylatedmonomerandPE-labeledstreptavidin.ItcontainsGly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)andHMTEVVRHCpeptide.（Endotoxin）Lessthan1EUperμgbytheLALmethod.制劑（Formulation）Suppliedas0.22μmfilteredsolutionin20mMPB,500mMNaCl,0.2%BSA(pH8.0).儲存條件Theproductshouldbestoredat-85~-65℃for3monthfromdateofreceipt.Recommendtoaliquottheproteinintosmallerquantitieswhenfirstusedandavoidrepeatedfreeze-thawcycles.

Recombinant Biotinylated Human HLA-A*03:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein,His-Avi Tag性能參數(shù)分子別名（Synonyms）MHC;KRAS;K-Ras2;KRAS2;C-K-RAS;CFC2;K-RAS2A;K-RAS2B;K-RAS4A;K-RAS4B;KRAS1;KRAS2;NS;NS3;RASK2;GTPaseKras;KI-RAS;RALD表達區(qū)間及表達系統(tǒng)（Source）BiotinylatedHumanHLA-A*03:01&B2M&KRASG12V(VVGAVGVGK)MonomerProteinisexpressedfromHEK293withHistagandAvitagattheC-TerminusItcontainsGly25-Thr305(HLA-A*03:01),Ile21-Met119(B2M)andVVGAVGVGKpeptide.[Accession|NP_002107.3(HLA-A*03:01)&P61769(B2M)&VVGAVGVGK]分子量大小（MolecularWeight）TheproteinhasapredictedMWof50.09kDa.Duetoglycosylation,theproteinmigratesto51-60kDabasedonSDS-PAGEresult.（Endotoxin）Lessthan1EUperμgbytheLALmethod.純度（Purity）>95%asdeterminedbySDS-PAGEandHPLC.制劑（Formulation）Suppliedas0.22μmfilteredsolutioninPBS(pH7.4).OSM與白血病抑制因子（LIF）密切相關(guān)，實際上，除了其在人類中的特定受體外，它實際上還使用了LIF受體。

Recombinant Biotinylated Human MSLN/Mesothelin Protein,hFc-Avi Tag分子別名（Synonyms）Mesothelin;CAK1;MSLN;MPFSMRP表達區(qū)間及表達系統(tǒng)（Source）BiotinylatedHumanMSLN/MesothelinProteinisexpressedfromHEK293withhFctagandAvitagattheC-Terminus.ItcontainsGlu296-Gly580.[Accession|Q13421-2]分子量大?。∕olecularWeight）TheproteinhasapredictedMWof61.1kDa.Duetoglycosylation,theproteinmigratesto70-80kDabasedonSDS-PAGEresult.（Endotoxin）Lessthan1EUperμgbytheLALmethod.純度（Purity）>95%asdeterminedbySDS-PAGEandHPLC.活性（Activity）ELISAData:ImmobilizedAnti-MSLNAntibody,hFcTagat1μg/ml(100μl/well)ontheplate.DoseresponsecurveforBiotinylatedHumanMSLN,hFcTagwiththeEC50of18.4ng/mldeterminedbyELISA.α-凝血酶（α-Thrombin）是一種高度特異性的絲氨酸蛋白酶，由凝血酶原經(jīng)蛋白水解活化而來。Recombinant Bovine GCP-2/CXCL6

甲磺酸達比加群酯是一種抗凝藥，通過競爭結(jié)合凝血酶的纖維蛋白特異結(jié)合位點，從而抑制血栓的形成。Recombinant Cynomolgus PSGL-1 Protein,His Tag

牙花(GPC)是硫酸肝素蛋白聚糖的一個家族,它是由糖磷酸肌醇(GPI)錨連接在細胞表面的。在哺乳動物中發(fā)現(xiàn)了這個家族的六名成員(GPC-GPC6)。已經(jīng)研制出幾種抗gpc3抗體。產(chǎn)品性質(zhì)同義詞Gpc3;dgsx;gbs1;sgbs1;sgbs1;工會編號P51654-1來源重組人的Gpc3/葡萄糖3蛋白表達于C-端的HK293細胞和AVI標(biāo)記。里面有GLN-25-559。分子量該蛋白質(zhì)的預(yù)測兆瓦為63.6kda。由于糖基化,蛋白質(zhì)遷移到42kda,80-135kda基于三聯(lián)頁面結(jié)果。純潔根據(jù)三-BIS頁面確定的90%產(chǎn)品用Lal法測定每一種蛋白質(zhì)。公式化在PBS(PPS)中用0.22離子過濾溶液凍干(PH7.4)。通常在凍干前添加5%海藻糖作為保護劑。重建離心管打開前。建議將其重組為超過100克/毫升的濃度(凍干時通常使用1毫克/毫升的溶液)。在蒸餾水中溶解凍干蛋白。Recombinant Cynomolgus PSGL-1 Protein,His Tag